The usage of SGLT-2 inhibitors in the management of heart failure in rural Africa: mitigating the barriers to the optimal adoption of a novel, adjuvant therapeutic agent in the management of heart failure

Ther Adv Cardiovasc Dis. 2023 Jan-Dec:17:17539447231202933. doi: 10.1177/17539447231202933.
No abstract available

Keywords: Africa; Heart failure; SGLT-2 inhibitors.

Publication types

  • Letter

MeSH terms

  • Adjuvants, Immunologic / therapeutic use
  • Africa / epidemiology
  • Diabetes Mellitus, Type 2* / diagnosis
  • Diabetes Mellitus, Type 2* / drug therapy
  • Heart Failure* / diagnosis
  • Heart Failure* / drug therapy
  • Humans
  • Hypoglycemic Agents / pharmacology
  • Hypoglycemic Agents / therapeutic use
  • Sodium-Glucose Transporter 2 Inhibitors* / adverse effects

Substances

  • Sodium-Glucose Transporter 2 Inhibitors
  • Hypoglycemic Agents
  • Adjuvants, Immunologic